The Type 2 Cytokine FC–IL-4 Revitalizes Exhausted CD8⁺ T Cells against Cancer

Researchers showed that an interleukin-4 fusion protein (Fc–IL-4) directly acted on CD8+ T cells and enriched functional terminally exhausted CD8+ T cells in the tumor.